A consortium of researchers from a number of top medical centers published a new study in JAMA Oncology assessing the ongoing lack of racial and ethnic diversity within clinical trials populations for cancer drugs. Yourway is invested in supporting new and evolving clinical trials paradigms that can help increase representation in clinical trials.